This article helps to lay the groundwork for understanding the hormonal impacts of gender affirming care and its effect upon esteogenic factors of thyroid cancer and can help to expidite cancer prevention and ensure that patients have sufficient background knoweldge of risks associated with lifelong treatment cycles